Skip to content

Geron GERN Payments for Royalties

Payments for Royalties at other companies

Geron logo
GeronGERN
$3.72M+1.1%
Universal Display logo
Universal DisplayOLED
$104K-8.8%
Ondas, Inc.
 logo
Ondas, Inc. ONDS
$85.5K+23.5%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$11.85M+47.2%
HTF
Heartflow, Inc. Common StockHTFL
$568K+37.2%
HealthStream logo
HealthStreamHSTM
$994K+134%

Other financials

Income statement

See full
Revenue$51.8M+30.9%
Operating income$158.0K+101%
Net income-$3.6M+81.6%
EPS (diluted)-$0.01+66.7%

Balance sheet

See full
Cash & equivalents$48.7M-12.2%
Total debt$134.0M+10.0%
Total equity$229.1M-14.6%
Total assets$534.1M-5.0%

Cash flow

See full
Operating cash flow-$62.9M-31.1%
CapEx$206.0K+2.0%
Free cash flow-$43.8M-6.8%

Valuation

See full
Market cap$878.88M-8.6%
Enterprise value$964.15M-6.2%
P/S4.7×-172×

Profitability

See full
Operating margin-705.5%-351pp
Net margin-682.5%-339pp
FCF margin-734.4%-365pp

Returns & leverage

See full
Return on equity-27.1%-7.8pp
Debt / equity0.6×+0.1×
Current ratio6.8×-1.1×

Where this comes from

Reported directly by Geron in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRoyalties.

The official record: Geron’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Geron's payments for royalties.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Geron's payments for royalties?
Geron (GERN) reported payments for royalties of $3.72M in Q1 2026.
How has Geron's payments for royalties changed year-over-year?
Geron's payments for royalties increased by 1.1% year-over-year, from $3.68M to $3.72M.
What does payments for royalties mean?
This represents the cash outflows made to third parties for the use of intellectual property or licensed technologies. It is a key operating expense for companies that rely on external innovation or collaborative development agreements. Tracking this helps investors understand the ongoing cost of maintaining the company's product pipeline and technology rights.